%0 Journal Article %1 Yan:2009:N-Engl-J-Med:19228619 %A Yan, H %A Parsons, D W %A Jin, G %A McLendon, R %A Rasheed, B A %A Yuan, W %A Kos, I %A Batinic-Haberle, I %A Jones, S %A Riggins, G J %A Friedman, H %A Friedman, A %A Reardon, D %A Herndon, J %A Kinzler, K W %A Velculescu, V E %A Vogelstein, B %A Bigner, D D %D 2009 %J N Engl J Med %K IDH1 IDH2 MUSTREAD astrocytoma cancer-research fulltext glioblastoma glioma initial_publication survival %N 8 %P 765-773 %R 10.1056/NEJMoa0808710 %T IDH1 and IDH2 mutations in gliomas %U https://www.ncbi.nlm.nih.gov/pubmed/19228619?dopt=Abstract %V 360 %X A recent genomewide mutational analysis of glioblastomas (World Health Organization WHO grade IV glioma) revealed somatic mutations of the isocitrate dehydrogenase 1 gene (IDH1) in a fraction of such tumors, most frequently in tumors that were known to have evolved from lower-grade gliomas (secondary glioblastomas).We determined the sequence of the IDH1 gene and the related IDH2 gene in 445 central nervous system (CNS) tumors and 494 non-CNS tumors. The enzymatic activity of the proteins that were produced from normal and mutant IDH1 and IDH2 genes was determined in cultured glioma cells that were transfected with these genes.We identified mutations that affected amino acid 132 of IDH1 in more than 70% of WHO grade II and III astrocytomas and oligodendrogliomas and in glioblastomas that developed from these lower-grade lesions. Tumors without mutations in IDH1 often had mutations affecting the analogous amino acid (R172) of the IDH2 gene. Tumors with IDH1 or IDH2 mutations had distinctive genetic and clinical characteristics, and patients with such tumors had a better outcome than those with wild-type IDH genes. Each of four tested IDH1 and IDH2 mutations reduced the enzymatic activity of the encoded protein.Mutations of NADP(+)-dependent isocitrate dehydrogenases encoded by IDH1 and IDH2 occur in a majority of several types of malignant gliomas.

@article{Yan:2009:N-Engl-J-Med:19228619, abstract = {A recent genomewide mutational analysis of glioblastomas (World Health Organization [WHO] grade IV glioma) revealed somatic mutations of the isocitrate dehydrogenase 1 gene (IDH1) in a fraction of such tumors, most frequently in tumors that were known to have evolved from lower-grade gliomas (secondary glioblastomas).We determined the sequence of the IDH1 gene and the related IDH2 gene in 445 central nervous system (CNS) tumors and 494 non-CNS tumors. The enzymatic activity of the proteins that were produced from normal and mutant IDH1 and IDH2 genes was determined in cultured glioma cells that were transfected with these genes.We identified mutations that affected amino acid 132 of IDH1 in more than 70% of WHO grade II and III astrocytomas and oligodendrogliomas and in glioblastomas that developed from these lower-grade lesions. Tumors without mutations in IDH1 often had mutations affecting the analogous amino acid (R172) of the IDH2 gene. Tumors with IDH1 or IDH2 mutations had distinctive genetic and clinical characteristics, and patients with such tumors had a better outcome than those with wild-type IDH genes. Each of four tested IDH1 and IDH2 mutations reduced the enzymatic activity of the encoded protein.Mutations of NADP(+)-dependent isocitrate dehydrogenases encoded by IDH1 and IDH2 occur in a majority of several types of malignant gliomas.}, added-at = {2018-12-29T11:30:41.000+0100}, author = {Yan, H and Parsons, D W and Jin, G and McLendon, R and Rasheed, B A and Yuan, W and Kos, I and Batinic-Haberle, I and Jones, S and Riggins, G J and Friedman, H and Friedman, A and Reardon, D and Herndon, J and Kinzler, K W and Velculescu, V E and Vogelstein, B and Bigner, D D}, biburl = {https://www.bibsonomy.org/bibtex/220792b5f7f1e98d3980e5631013ce18d/marcsaric}, description = {IDH1 and IDH2 mutations in gliomas. - PubMed - NCBI}, doi = {10.1056/NEJMoa0808710}, interhash = {1bfa86e881374e1fafe4085591fa49b7}, intrahash = {20792b5f7f1e98d3980e5631013ce18d}, journal = {N Engl J Med}, keywords = {IDH1 IDH2 MUSTREAD astrocytoma cancer-research fulltext glioblastoma glioma initial_publication survival}, month = feb, number = 8, pages = {765-773}, pmid = {19228619}, timestamp = {2018-12-29T11:30:41.000+0100}, title = {IDH1 and IDH2 mutations in gliomas}, url = {https://www.ncbi.nlm.nih.gov/pubmed/19228619?dopt=Abstract}, volume = 360, year = 2009 }